According to Burning Rock Biotech's latest financial reports the company has a price-to-book ratio of 0.6460.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 0.7927 | -44.04% |
2022-12-31 | 1.42 | -58.83% |
2021-12-31 | 3.44 | -47.12% |
2020-12-31 | 6.51 | |
2019-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
LabCorp LH | 2.14 | 231.15% | ๐บ๐ธ USA |
OpGen
OPGN | 2.18 | 236.97% | ๐บ๐ธ USA |
NeoGenomics
NEO | 2.00 | 209.07% | ๐บ๐ธ USA |